To evaluate the immunomodulatory property of fluoxetine, independently of the viral load, we used the A549-DualTM cells consisting in a human NF-κB-SEAP & IRF-Luc Reporter lung carcinoma cell line. The gene discussed is NFKB1; the disease is lung carcinoma.